McNicoll Lewis & Vlak Upgrades Transcept Pharmaceuticals to Buy, $21 PT

Symbols: TSPT
Share

McNicoll Lewis & Vlak has upgraded Transcept Pharmaceuticals (NASDAQ: TSPT) from Hold to Buy and has established a $21 price target.


 
 
< Previous
End-of-Day Market Summary for October 31, 2011
Next >
JP Morgan Upgrades Post Properties to Neutral, $34 PT
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust